Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sinemet "abusers".

P A Nausieda

    Clinical Neuropharmacology
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Parkinson's patients may develop psychological dependence on levodopa, leading to dosage escalation and toxicity. This dependence, distinct from motor symptom perception, requires further investigation in Parkinson's disease management.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Too many treatments for Parkinson's disease: how should they be used?

    WMJ : official publication of the State Medical Society of Wisconsin·2000
    Same author

    Psychiatric complications of levodopa therapy of Parkinson's disease.

    Advances in neurology·1984
    Same author

    Chronic dopaminergic sensitivity after Sydenham's chorea.

    Neurology·1983
    Same author

    Serotonergically active agents in levodopa-induced psychiatric toxicity reactions.

    Advances in neurology·1983
    Same author

    Levodopa-free periods ("drug holidays") in the management of parkinsonism.

    Advances in neurology·1983
    Same author

    Parkinsonian features and progressive supranuclear palsy.

    Archives of neurology·1982
    Same journal

    Characterization of Propranolol Use and Outcomes in Traumatic Brain Injury at a Level I Trauma Center.

    Clinical neuropharmacology·2026
    Same journal

    Review of Medications That Reduce Neurological Deficits in Patients With Traumatic Brain Injury.

    Clinical neuropharmacology·2026
    Same journal

    Pre-Existing Peak-Dose Dyskinesia and Light Body Weight as Predictors of Ropinirole Patch Dose Modification in Parkinson Disease: A Multicenter Retrospective Study.

    Clinical neuropharmacology·2026
    Same journal

    A Double-blind, Placebo-controlled Study of Lumateperone in the Treatment of Borderline Personality Disorder.

    Clinical neuropharmacology·2026
    Same journal

    Yesterday Once More: Revisiting Catatonia in an Elderly Stroke Patient.

    Clinical neuropharmacology·2026
    Same journal

    Overlapping Hyperosmolar Therapy in Patients With Elevated and Refractory Intracranial Pressure.

    Clinical neuropharmacology·2026
    See all related articles

    Area of Science:

    • Neurology
    • Psychiatry
    • Pharmacology

    Background:

    • Parkinsonian patients typically adjust antiparkinsonian drug dosages based on motor symptoms.
    • Levodopa is a primary treatment for Parkinson's disease, aiming to alleviate motor deficits.

    Observation:

    • Five patients with Parkinson's disease exhibited psychological effects from levodopa.
    • These psychological effects led to increased levodopa dosage, resulting in toxicity.
    • Drug-seeking behavior emerged upon withdrawal of dopaminergic drugs.

    Findings:

    • Psychological dependence on levodopa, independent of motor symptom perception, was observed.
    • This dependence appears to affect a small subset of Parkinson's patients.
    • The study challenges the assumption that drug need is solely based on motor symptoms.

    Related Experiment Videos

    Implications:

    • This finding suggests a need to monitor for psychological dependence in Parkinson's patients on levodopa.
    • Clinical management of Parkinson's disease may need to consider psychological factors alongside motor symptoms.
    • Further research is warranted to understand the mechanisms and prevalence of levodopa dependence.